|
US 12,227,773 B2 |
|
| Recombinase polymerase amplification |
| Olaf Piepenburg, Cambridge (GB); Niall A. Armes, Essex (GB); and Matthew James David Parker, Hertfordshire (GB) |
| Assigned to ABBOTT DIAGNOSTICS SCARBOROUGH, INC., San Diego, CA (US) |
| Filed by ABBOTT DIAGNOSTICS SCARBOROUGH, INC., San Diego, CA (US) |
| Filed on May 23, 2022, as Appl. No. 17/750,758. |
| Application 17/750,758 is a continuation of application No. 16/155,133, filed on Oct. 9, 2018, granted, now 11,339,382, issued on May 24, 2022. |
| Application 16/155,133 is a continuation of application No. 14/135,227, filed on Dec. 19, 2013, granted, now 10,093,908, issued on Oct. 9, 2018. |
| Application 14/135,227 is a continuation of application No. 13/307,293, filed on Nov. 30, 2011, granted, now 8,637,253, issued on Jan. 28, 2014. |
| Application 13/307,293 is a continuation of application No. 11/800,318, filed on May 4, 2007, granted, now 8,071,308, issued on Dec. 6, 2011. |
| Claims priority of provisional application 60/798,060, filed on May 4, 2006. |
| Prior Publication US 2023/0242889 A1, Aug. 3, 2023 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C12N 9/12 (2006.01); C12N 9/00 (2006.01); C12Q 1/6844 (2018.01) |